PA
TMO icon

Probity Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Probity Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$227K Sell
453
-46
-9% -$22.1K 0.03% 222
2026
Q1 		$245K Sell
499
-9
-2% -$4.88K 0.04% 217
2025
Q4 		$294K Sell
508
-74
-13% -$41.8K 0.05% 203
2025
Q3 		$282K Sell
582
-13
-2% -$6.05K 0.05% 207
2025
Q2 		$241K Buy
595
+184
+45% +$76.9K 0.04% 211
2025
Q1 		$205K Buy
+411
New +$223K 0.04% 223

Other funds holding TMO

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Probity Advisors's TMO Position: Q2 2026 in Review

Probity Advisors reduced its Thermo Fisher Scientific (TMO) stake by 9.2% in Q2 2026, selling an estimated $22.1K and leaving 453 shares worth $227K. The position accounts for 0.03% of the portfolio, ranked #222.

Probity Advisors first reported a position in TMO in Q1 2025 and has held it in 6 quarters since. The position peaked at $294K in Q4 2025. 1,323 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Probity Advisors held 453 shares of Thermo Fisher Scientific worth $227K as of Q2 2026.
  • Probity Advisors sold 46 Thermo Fisher Scientific shares in Q2 2026, an estimated $22.1K.
  • Thermo Fisher Scientific made up 0.03% of Probity Advisors's portfolio in Q2 2026, its #222 holding.
  • Probity Advisors first reported a position in Thermo Fisher Scientific in Q1 2025 and has held it in 6 quarters since.
  • Probity Advisors's Thermo Fisher Scientific position peaked at $294K in Q4 2025.
  • 1,323 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Probity Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.